SAB Biotherapeutics, Inc. - SABS
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 20
Latest filed: Sep 18, 2026
| Form | Count |
|---|---|
| SCHEDULE 13G/A | 7 |
| SCHEDULE 13G | 4 |
| 8-K | 4 |
| 4 | 3 |
| SCHEDULE 13D/A | 2 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Sep 18, 2026 | 4 | Sep 17, 2026 | 0001193125-26-395552 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | — | 0001193125-26-352646 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | — | 0001727492-26-000022 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | — | 0001213900-26-090054 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | — | 0001831942-26-000035 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | — | 0000919574-26-005263 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | — | 0001172661-26-003437 | View |
| Aug 12, 2026 | SCHEDULE 13G | — | 0000919574-26-004984 | View |
| Aug 10, 2026 | SCHEDULE 13D/A | — | 0001346824-26-000220 | View |
| Jul 07, 2026 | 8-K | Jul 07, 2026 | 0001193125-26-296936 | View |
| Jun 26, 2026 | 4 | Jun 25, 2026 | 0001193125-26-285722 | View |
| Jun 18, 2026 | 8-K | Jun 18, 2026 | 0001193125-26-275976 | View |
| May 15, 2026 | SCHEDULE 13G/A | — | 0001193125-26-226560 | View |
| May 15, 2026 | SCHEDULE 13G | — | 0001727492-26-000011 | View |
| May 15, 2026 | SCHEDULE 13G | — | 0001193125-26-225169 | View |
| May 04, 2026 | 8-K | Apr 28, 2026 | 0001193125-26-204125 | View |
| May 01, 2026 | SCHEDULE 13G | — | 0001104659-26-054220 | View |
| Apr 22, 2026 | 8-K | Apr 22, 2026 | 0001193125-26-168569 | View |
| Mar 25, 2026 | 4 | Mar 24, 2026 | 0001193125-26-124231 | View |
| Mar 23, 2026 | SCHEDULE 13D/A | — | 0001346824-26-000079 | View |